CA2612149C - Mixture of catechins or rather polyphenols extracted from chinese green tea or other vegetables with chemically preventive efficacy for prevention of prostate cancer onset and forefficacious treatment of symptomatology of prostate hypertrophy (bph) - Google Patents

Mixture of catechins or rather polyphenols extracted from chinese green tea or other vegetables with chemically preventive efficacy for prevention of prostate cancer onset and forefficacious treatment of symptomatology of prostate hypertrophy (bph) Download PDF

Info

Publication number
CA2612149C
CA2612149C CA2612149A CA2612149A CA2612149C CA 2612149 C CA2612149 C CA 2612149C CA 2612149 A CA2612149 A CA 2612149A CA 2612149 A CA2612149 A CA 2612149A CA 2612149 C CA2612149 C CA 2612149C
Authority
CA
Canada
Prior art keywords
catechins
mixture
gallate
less
epigallocatechin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2612149A
Other languages
English (en)
French (fr)
Other versions
CA2612149A1 (en
Inventor
Saverio Bettuzzi
Arnaldo Corti
Sergio Corvetta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genprofiler Srl
Original Assignee
Genprofiler Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITBZ20040037 external-priority patent/ITBZ20040037A1/it
Priority claimed from ITBZ20050004 external-priority patent/ITBZ20050004A1/it
Application filed by Genprofiler Srl filed Critical Genprofiler Srl
Publication of CA2612149A1 publication Critical patent/CA2612149A1/en
Application granted granted Critical
Publication of CA2612149C publication Critical patent/CA2612149C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
CA2612149A 2004-07-27 2005-07-21 Mixture of catechins or rather polyphenols extracted from chinese green tea or other vegetables with chemically preventive efficacy for prevention of prostate cancer onset and forefficacious treatment of symptomatology of prostate hypertrophy (bph) Expired - Lifetime CA2612149C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
ITBZ20040037 ITBZ20040037A1 (it) 2004-07-27 2004-07-27 Miscela di catechine ovvero polifenoli estratti dal te' verde cinese o da altri vegetali con efficacia chemiopreventiva per la prevenzione dell'insorgenza del cancro prostatico.
ITBZ2004A000037 2004-07-27
ITBZ20050004 ITBZ20050004A1 (it) 2005-02-16 2005-02-16 Miscela di catechine ovvero polifenoli estratti dal Te' Verde cinese (o da altri vegetali) Efficacia chemiopreventiva per la prevenzione dell'insorgenza del cancro prostatico e per il trattamento efficace della sintomatologia dell'ipertrofia prostati
ITBZ2005A000004 2005-02-16
PCT/IB2005/002107 WO2006013420A2 (en) 2004-07-27 2005-07-21 Mixture of catechins or rather polyphenols extracted from chinese green tea or other vegetables for the prevention of prostate cancer and for the treatment of prostate hypertrophy (bph)

Publications (2)

Publication Number Publication Date
CA2612149A1 CA2612149A1 (en) 2006-02-09
CA2612149C true CA2612149C (en) 2015-11-10

Family

ID=35447932

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2612149A Expired - Lifetime CA2612149C (en) 2004-07-27 2005-07-21 Mixture of catechins or rather polyphenols extracted from chinese green tea or other vegetables with chemically preventive efficacy for prevention of prostate cancer onset and forefficacious treatment of symptomatology of prostate hypertrophy (bph)

Country Status (7)

Country Link
US (1) US8044095B2 (enExample)
EP (1) EP1781375B1 (enExample)
JP (2) JP2008508252A (enExample)
CA (1) CA2612149C (enExample)
ES (1) ES2427170T3 (enExample)
PL (1) PL1781375T3 (enExample)
WO (1) WO2006013420A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2214688B1 (en) 2007-10-26 2018-09-05 Csir Management and treatment of benign prostatic hyperplasia
FR2930443B1 (fr) 2008-04-29 2010-06-25 Oreal Produit extemporane de soin a base d'un lyophilisat de microorganisme et de tensioactif(s) de hlb superieur ou egal a 12
PL2348838T3 (pl) * 2008-10-20 2013-10-31 Unilever Nv Antybakteryjna kompozycja
AU2010297406B2 (en) 2009-09-24 2013-10-17 Unilever Plc Disinfecting agent comprising eugenol, terpineol and thymol
MX2013006435A (es) 2010-12-07 2013-07-03 Unilever Nv Composicion para cuidado oral.
CN103998011B (zh) 2011-11-03 2016-11-23 荷兰联合利华有限公司 个人清洁组合物
IN2014MN00931A (enExample) * 2011-11-25 2015-04-17 Unilever Plc
WO2013081046A1 (ja) * 2011-11-29 2013-06-06 国立大学法人信州大学 ブドウ梗由来抽出物
CN102754832A (zh) * 2012-07-12 2012-10-31 赵四海 用酚和醌融解肿瘤和改造癌细胞的治病方法
JP6279591B2 (ja) * 2012-10-15 2018-02-14 ケミン、インダストリーズ、インコーポレーテッドＫｅｍｉｎ Ｉｎｄｕｓｔｒｉｅｓ， Ｉｎｃ． 健康を促進するための緑茶抽出物と紅茶抽出物との混合物
KR101492713B1 (ko) * 2013-05-06 2015-02-12 대구한의대학교산학협력단 미숙 떫은 감의 분획물을 이용한 전립선 비대증 예방 또는 치료용 조성물
AU2018352167B2 (en) 2017-10-19 2024-03-14 Yale University Inhibition of androgen receptor by extracts of medicinal herbs and compositions thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266977A (en) * 1991-07-12 1993-11-30 Linden Harry A Lens device and method
US5585871A (en) * 1995-05-26 1996-12-17 Linden; Harry Multi-function display apparatus
US6696484B2 (en) 1997-10-31 2004-02-24 University Of Chicago Office Of Technology And Intellectual Property Method and compositions for regulation of 5-alpha reductase activity
DE19842858A1 (de) 1998-09-18 2000-03-30 Vollbrecht H Ruediger Entkoffeinierung von Tee
KR100319973B1 (ko) 1998-12-05 2002-04-22 이인수 녹차카테킨을 유효성분으로 하는 자궁경부 상피내종양 예방 또는 치료제 조성물
AU4043900A (en) * 1999-03-30 2000-10-16 Purdue Research Foundation Compositions containing tea catechins as cancer specific proliferation inhibitors
US6410052B1 (en) * 1999-03-30 2002-06-25 Purdue Research Foundation Tea catechins in sustained release formulations as cancer specific proliferation inhibitors
US6431705B1 (en) * 1999-11-10 2002-08-13 Infoeye Eyewear heart rate monitor
WO2002067965A1 (en) 2001-02-22 2002-09-06 Purdue Research Foundation Compositions based on proanthocyanadin-catechin synergies for prevention and treatment of cancer
US6759064B2 (en) * 2001-02-22 2004-07-06 Purdue Research Foundation Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer

Also Published As

Publication number Publication date
EP1781375A2 (en) 2007-05-09
JP2012236834A (ja) 2012-12-06
ES2427170T3 (es) 2013-10-29
JP2008508252A (ja) 2008-03-21
CA2612149A1 (en) 2006-02-09
US20080194675A1 (en) 2008-08-14
WO2006013420A2 (en) 2006-02-09
US8044095B2 (en) 2011-10-25
PL1781375T3 (pl) 2013-11-29
WO2006013420B1 (en) 2006-06-08
WO2006013420A3 (en) 2006-04-20
EP1781375B1 (en) 2013-06-19

Similar Documents

Publication Publication Date Title
Yan et al. Antioxidant mechanism of tea polyphenols and its impact on health benefits
Mei et al. Diosmetin alleviated cerebral ischemia/reperfusion injury in vivo and in vitro by inhibiting oxidative stress via the SIRT1/Nrf2 signaling pathway
Sharafati-Chaleshtori et al. Melatonin and human mitochondrial diseases
JP2012236834A (ja) 前立腺癌の予防および前立腺肥大（ｂｐｈ）の処置のための中国緑茶またはその他の野菜から抽出したカテキン、さらに正確にはポリフェノールの混合物
Martin et al. Polyphenols as dietary supplements: A double-edged sword
Kahraman et al. The antioxidative and antihistaminic properties of quercetin in ethanol-induced gastric lesions
Rajalakshmi et al. Assessment of the no-observed-adverse-effect level (NOAEL) of gallic acid in mice
Chuah et al. In vitro and in vivo toxicity of garcinia or hydroxycitric acid: a review
Tangpong et al. Alleviation of lead poisoning in the brain with aqueous leaf extract of the Thunbergia laurifolia (Linn.)
Khan et al. Antiobesity, hypolipidemic, antioxidant and hepatoprotective effects of Achyranthes aspera seed saponins in high cholesterol fed albino rats
WO2007021034A1 (ja) 生体内の有害な活性酸素及び／又はフリーラジカル除去剤
Phyu et al. Protective effect of Thunbergia laurifolia (Linn.) on lead induced acetylcholinesterase dysfunction and cognitive impairment in mice
Diao et al. Antioxidant and antiapoptotic polyphenols from green tea extract ameliorate CCl4-induced acute liver injury in mice
Bawono et al. The role of catechins of Camellia sinensis leaves in modulating antioxidant enzymes: A review and case study
Daniel et al. In vivo antidiabetic and antioxidant activities of chloroform fraction of Nelsonia canescens Leaf in Alloxan-induced Diabetic Rats
KR101447231B1 (ko) 숙취해소환의 제조 방법 및 상기 방법에 의하여 제조된 숙취해소환
Tsao Inhibiting effect of ascorbic acid on the growth of human mammary tumor xenografts
Mahmood et al. The impact of green tea (Camellia sinensis) on the amount of gonadotropin hormones (LH, FSH) in immature female rats poisoned with cadmium chloride
KR20180101411A (ko) 전립선 비대증 치료를 위한 약제학적 조성물
Abeed et al. Evaluation of the potential protective role of Galangin associated with gold nanoparticles in the histological and functional structure of testes of adult male albino mice administrated with carbon tetrachloride
WO2004112766A1 (en) Composition for lowering blood glucose
Singh et al. Evaluation of hepatoprotective efficacy of a polyherbal Unani formulation Majoon-Najah against cadmium chloride-induced liver damage
Kashani et al. Different traditional methods of Nux-Vomica detoxification have therapeutic rationales
Stevens et al. Xanthohumol, what a delightful problem child!
Abd-Alhassen et al. In vitro and in vivo antioxidant activity of Iraqi propolis against benign prostatic hyperplasia in rats

Legal Events

Date Code Title Description
EEER Examination request